Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00840008
Other study ID # MCT-88113
Secondary ID
Status Completed
Phase Phase 4
First received February 4, 2009
Last updated August 25, 2011
Start date September 2008
Est. completion date December 2010

Study information

Verified date August 2011
Source McGill University Health Center
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess whether adherence to NVUGIB guidelines is improved with implementation of a national, tailored multifaceted intervention. Outcomes include adherence rates to two key endoscopic and pharmacological therapy guidelines together (primary), or adherence to these individually as well as to other recommendations (secondary). Patient outcomes and economic data are also assessed (tertiary).


Description:

Clusters are randomized to receive a published algorithm and guidelines (control group), or a multifaceted, tailored educational intervention (see details in protocol - intervention group). The charts of treated patients with non variceal upper GI bleeding are reviewed and adherence to selected guidelines recorded.


Recruitment information / eligibility

Status Completed
Enrollment 3157
Est. completion date December 2010
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 or over.

- Treated during the study duration

- Primary or secondary discharge diagnoses of NVUGIB (per charted ICD-10 code). Additional confirmation of NVUGIB using endoscopic findings or patient symptoms done as previous.

Exclusion Criteria:

- Patients initially assessed at another institution for the present episode of NVUGIB and subsequently transferred to the participating site with unavailable initial data.

- Endoscopy noted no gastro-duodenal ulcer bleeding, to ensure patient homogeneity.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Intervention

Other:
Educational intervention
As per detailed protocol.

Locations

Country Name City State
n/a

Sponsors (39)

Lead Sponsor Collaborator
McGill University Health Center Centre Hospitalier Anna Laberge, Centre hospitalier de l'Université de Montréal (CHUM), Centre Hospitalier Pierre Boucher, CHAUQ - Hopital Saint Sacrement and Hopital Enfant Jesus, Cité de la Santé Hospital, Foothills Medical Centre, Grey Nuns Hospital, Guelph General Hospital, Hamilton Health Sciences Corporation, Horizon Health Network, Hotel Dieu Hospital, Hôtel-Dieu de Lévis, Jewish General Hospital, Kingston General Hospital, Lakeridge Health Corporation, London Health Sciences Centre, Maisonneuve-Rosemont Hospital, Matsqui-Sumas-Abbotsford General Hospital and Mission Memorial Hospital, Misericordia, MUHC - Montreal General Hospital, Peter Lougheed Centre/The Calgary General Hospital, QEII Health Sciences Centre, Regina General Hospital, Rockyview General Hospital, Royal Alexandra Hospital, Royal University Hospital Foundation, Royal Victoria Hospital, Canada, Scarborough General Hospital, St Mary's Hospital, London, St-Johns Health Sciences Centre, St. Joseph Hospital Health Center, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Toronto General Hospital, University of Alberta, University of Manitoba, Vancouver General Hospital, York Central Hospital, Ontario

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to guidelines G10 and G17 of the 2003 International Consensus Guidelines on nonvariceal upper GI bleeding. 1 year No
Secondary Adherence to guidelines G10 or G17 alone, G5b, G6, G7a, G7b , G7c, G18 of the 2003 International Consensus Conference on nonvariceal upper GI bleeding. 1 year No
See also
  Status Clinical Trial Phase
Completed NCT01125852 - Supplementary Angiographic Embolization for Peptic Ulcer Bleeding N/A
Terminated NCT00164905 - Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage N/A
Completed NCT05563714 - Anticoagulation With Enhanced Gastrointestinal Safety N/A
Completed NCT03362281 - Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Phase 3
Completed NCT00164931 - A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer Phase 3
Completed NCT04211194 - Registry for Upper Gastrointestinal Bleeding
Completed NCT01241266 - China Survey of Peptic Ulcer Bleeding N/A
Completed NCT00037570 - Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage Phase 2
Completed NCT00731601 - Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding Phase 4
Completed NCT05248321 - Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding N/A
Recruiting NCT00687336 - Helicobacter Pylori Empiric Treatment in Ulcer Bleeding Phase 4
Not yet recruiting NCT06273384 - Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
Terminated NCT00165009 - Resolution Endoclips Vs Epinephrine Injection and Heater Probe Phase 3
Completed NCT03163680 - Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
Completed NCT00279123 - Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers Phase 4
Completed NCT03362268 - IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Phase 2
Completed NCT00573924 - Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers N/A
Withdrawn NCT02724150 - Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding Phase 4
Active, not recruiting NCT04536428 - ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding N/A
Completed NCT02197039 - The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers